This site is best experienced with JavaScript enabled.

KYNMOBI (apomorphine HCl) sublingual film is a prescription medicine used to treat short-term (acute), intermittent OFF episodes in people with Parkinson’s disease (PD).1

Now Approved

The FIRST AND ONLY sublingual treatment for OFF episodes in Parkinson's disease

AVAILABLE
SEPTEMBER 2020

SIGN UP FOR UPDATES

Register to receive updates about the first and only sublingual film, prescription medicine used to treat OFF episodes associated with Parkinson's disease.

I am a...

*Required field

Sunovion Pharmaceuticals Inc. respects your information.

*

Please see the most recent version of our privacy policy, which may change from time to time.

To be removed from our mailing list, please visit our unsubscribe page or call 1-844-596-6624.

AVAILABLE
SEPTEMBER 2020
Sunovion Answers Logo

For More information,
call Sunovion Answers

1-844-596-6624

Learn More about KYNMOBI

Q:
What is KYNMOBI?
KYNMOBI (apomorphine HCI) sublingual film is a prescription medicine used to treat short-term (acute) intermittent “off” episodes in people with Parkinson’s disease (PD).1

KYNMOBI is administered under-the-tongue.1

Please see the Patient Information, Full Prescribing Information, and Instructions For Use on how to take KYNMOBI or contact Sunovion Answers Plus at 1-844-596-6624.

The most common side effects of KYNMOBI include nausea, sleepiness, dizziness, and mouth swelling, pain, or sores.1

KYNMOBI may cause the following serious side effects:

  • Nausea and vomiting1
  • Sleepiness and falling asleep while engaged in activities1
  • Hypersensitivity1
  • Dizziness1
  • Oral irritation1
  • Falls1
  • Hallucinations and psychotic-like behavior1
  • Intense urges1
  • Fever and confusion1
  • Heart problems1
  • Tissue changes (fibrotic complications)1
  • Prolonged painful erections (priapism)1

For additional information, please see the Patient Information and Important Safety Information or contact Sunovion Answers Plus at 1-844-596-6624.

KYNMOBI is indicated for the treatment of OFF episodes in Parkinson's disease, including1:

  • Morning OFF You may wake up with OFF symptoms because your last dose of levodopa prior to bedtime is wearing OFF. Additionally, after you take your first dose of levodopa, you may experience OFF symptoms until that dose takes effect (delayed ON)2
  • Wearing OFF and Delayed ON You may experience OFF symptoms during the rest of the day that happen when your levodopa wears OFF (wearing OFF) or a new dose takes longer to take effect (delayed ON)2
  • Unpredictable/Unexpected OFF You may have other OFF times throughout the day that happen suddenly without any warning and are not necessarily related to the timing of your levodopa doses2
Make sure to fill out the registration form above to receive more information about KYNMOBI.

Important Safety Information and Indication for KYNMOBI (apomorphine hydrochloride) SUBLINGUAL FILM

Do not take KYNMOBI if you are taking certain medicines to treat nausea called 5HT3 antagonists, including ondansetron, granisetron, dolasetron, palonosetron, and alosetron. People taking ondansetron together with apomorphine, the active ingredient in KYNMOBI, have had very low blood pressure and lost consciousness or “blacked out.”

Thank you for registering at KYNMOBI.com!

We look forward to telling you more about KYNMOBI, a new medication to treat OFF episodes associated with Parkinson's disease, as it becomes available.

You have been successfully unsubscribed.

Please allow 7-10 days to process your request.